Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans
|
9 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.850 | 1.000 | 5 | 1999 | 2018 | ||||||
THANATOPHORIC DYSPLASIA, TYPE I (disorder)
|
18 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.840 | 1.000 | 10 | 1995 | 2016 | ||||||
Achondroplasia
|
21 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.800 | 1.000 | 6 | 1994 | 2002 | ||||||
Thanatophoric dysplasia, type 2
|
17 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.730 | 0.667 | 3 | 1999 | 2018 | ||||||
Hypochondroplasia (disorder)
|
42 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.720 | 1.000 | 2 | 2008 | 2018 | ||||||
Craniosynostosis
|
90 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.710 | 0.833 | 6 | 1999 | 2016 | ||||||
Seborrheic keratosis
|
21 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 1.000 | 1 | 2005 | 2005 | ||||||
CATSHL syndrome
|
10 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
Cervix carcinoma
|
283 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
Colorectal Carcinoma
|
1962 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder)
|
8 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
Lacrimoauriculodentodigital syndrome
|
33 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
Malignant neoplasm of testis
|
31 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
Malignant neoplasm of urinary bladder
|
316 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
Muenke Syndrome
|
11 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
NEVUS, EPIDERMAL (disorder)
|
17 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
SEVERE ACHONDRODYSPLASIA WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS
|
1 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.700 | 0 | |||||||||
Acanthosis Nigricans
|
11 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.040 | 1.000 | 4 | 1999 | 2018 | ||||||
Familial acanthosis nigricans
|
1 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2007 | 2018 | ||||||
Osteochondrodysplasias
|
26 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||
Skeletal dysplasia
|
65 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||
Abnormality of the skeletal system
|
18 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Adult Lymphoma
|
66 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Childhood Lymphoma
|
66 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Developmental delay (disorder)
|
68 | 0.653 | 0.600 | 4 | 1806163 | missense variant | A/C;T | snv | 0.010 | 1.000 | 1 | 1999 | 1999 |